A Letter from our CEO

When I wrote my last “letter from the CEO” in January 2020, I did not foresee the tumultuous year ahead. For so many, it’s been a tragic and difficult year on a personal level. We have all been impacted by the pandemic...

Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

CBSA President & CEO, Jennifer Jones Paton, asked Michael Artinger, PhD, Neurexis’ Chief Executive Officer, CBSA’s Key Questions for Life Sciences Innovators.

VIC Investor Network Introduces a Secondary Market for Members

Provides VIN Members Early Liquidity Options FAYETTEVILLE, AR. DECEMBER 14, 2020- The VIC Investor Network (“VIN”) makes investments into companies based on technologies that can have substantial impact on human health...

SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation

FDA’s BDD program targets novel devices with the potential to provide patients with a more effective treatment for life-threatening or irreversibly debilitating diseases. SFC’s insulin pod promises to substantially...

VIC Portfolio Company, BlueInGreen, Acquired by Chart Industries

Arkansas-based cleantech company tapped to lead Chart’s global water and wastewater treatment markets Water cleantech company BlueInGreen, LLC—provider of the most efficient method of dissolving oxygen, carbon dioxide...

Inside The VIC Fellows Program

VIC Technology Venture Development’s (www.victech.com) investment model sources promising life science innovation directly from universities across the nation, allocating funding to form startup companies and advance...

VIC Fellows Spotlight: Travis Nemkov, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Tesseract Structural Innovations and Cymat Technologies Announce Co-Operation Agreement

Combines Tesseract’s engineered product innovations and Cymat’s stabilized aluminum foam in automotive, aerospace, transportation, nuclear transport, military and defense applications.

VIC Foundry: An Incubator for High Impact Life Science Technologies

What is VIC Foundry? VIC Foundry is one element of the VIC innovation ecosystem. It develops technologies sourced from top research institutions in the U.S. with the potential to have substantial impact and commercial...

Sustainability as Strategy: A Discussion with BlueInGreen

A Discussion with BlueInGreen Chief Marketing + Sustainability Officer Tyler Elm For those unfamiliar with BlueInGreen, tell us a little about the Company. BlueInGreen (BIG) is a remarkable, water clean-tech company....

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix